FI52851C - Process for the preparation of the novel therapeutically useful peptide antibiotics S 7481 / F-1 and S 7481 / F-2. - Google Patents

Process for the preparation of the novel therapeutically useful peptide antibiotics S 7481 / F-1 and S 7481 / F-2.

Info

Publication number
FI52851C
FI52851C FI743434A FI343474A FI52851C FI 52851 C FI52851 C FI 52851C FI 743434 A FI743434 A FI 743434A FI 343474 A FI343474 A FI 343474A FI 52851 C FI52851 C FI 52851C
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
peptide antibiotics
useful peptide
novel therapeutically
Prior art date
Application number
FI743434A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI52851B (en
FI343474A (en
Inventor
Eugen Haerri
Artur Rueegger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI52851(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/en
Priority claimed from CH1404374A external-priority patent/CH603790A5/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI343474A publication Critical patent/FI343474A/fi
Priority to FI771201A priority Critical patent/FI54606C/en
Application granted granted Critical
Publication of FI52851B publication Critical patent/FI52851B/fi
Publication of FI52851C publication Critical patent/FI52851C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI743434A 1973-12-06 1974-11-27 Process for the preparation of the novel therapeutically useful peptide antibiotics S 7481 / F-1 and S 7481 / F-2. FI52851C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI771201A FI54606C (en) 1973-12-06 1977-04-15 PROCEDURE FOR FRAMSTATION OF THE PEPTIDANTIBIOTICS S 7481 / F-1 OCH S 7481 / F-2

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2

Publications (3)

Publication Number Publication Date
FI343474A FI343474A (en) 1975-06-07
FI52851B FI52851B (en) 1977-08-31
FI52851C true FI52851C (en) 1977-12-12

Family

ID=25713544

Family Applications (2)

Application Number Title Priority Date Filing Date
FI743434A FI52851C (en) 1973-12-06 1974-11-27 Process for the preparation of the novel therapeutically useful peptide antibiotics S 7481 / F-1 and S 7481 / F-2.
FI771201A FI54606C (en) 1973-12-06 1977-04-15 PROCEDURE FOR FRAMSTATION OF THE PEPTIDANTIBIOTICS S 7481 / F-1 OCH S 7481 / F-2

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI771201A FI54606C (en) 1973-12-06 1977-04-15 PROCEDURE FOR FRAMSTATION OF THE PEPTIDANTIBIOTICS S 7481 / F-1 OCH S 7481 / F-2

Country Status (19)

Country Link
JP (1) JPS5615235B2 (en)
AU (1) AU500889B2 (en)
CA (1) CA1030469A (en)
DD (1) DD115695A5 (en)
DE (2) DE2463138C2 (en)
DK (1) DK136780B (en)
ES (1) ES432559A1 (en)
FI (2) FI52851C (en)
FR (1) FR2253531B1 (en)
GB (1) GB1491509A (en)
HK (1) HK53880A (en)
IE (1) IE40549B1 (en)
IL (1) IL46180A (en)
MY (1) MY8100203A (en)
NL (1) NL179220C (en)
NO (1) NO744292L (en)
NZ (1) NZ176117A (en)
PH (1) PH13773A (en)
SE (1) SE423720B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (en) 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
FI65914C (en) * 1978-03-07 1984-08-10 Sandoz Ag FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
SE448386B (en) * 1978-10-18 1987-02-16 Sandoz Ag NEW CYCLOSPORIN DERIVATIVES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
DE3167014D1 (en) * 1980-02-14 1984-12-13 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
DE3260468D1 (en) 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
JPS59129920U (en) * 1983-02-16 1984-08-31 日立造船株式会社 Opening/closing device for bypass valve with gate
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
EP0484281B2 (en) 1990-11-02 2000-11-22 Novartis AG Cyclosporins
CA2101777A1 (en) * 1991-01-25 1992-07-26 Toshio Goto Process for producing cyclosporin a and/or c
KR100304324B1 (en) * 1994-10-13 2001-11-22 김용규 Method for manufacturing cyclosporine a
EP0789580B1 (en) 1994-11-03 2002-06-05 Novartis AG Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
WO2004082629A2 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (en) 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2151450A1 (en) 2008-07-29 2010-02-10 Sandoz AG Method for processing microbiologically produced cyclic oligopeptides

Also Published As

Publication number Publication date
AU500889B2 (en) 1979-06-07
SE7415027L (en) 1975-06-09
HK53880A (en) 1980-10-03
FI54606B (en) 1978-09-29
GB1491509A (en) 1977-11-09
DE2463138C2 (en) 1984-07-05
IL46180A (en) 1978-07-31
MY8100203A (en) 1981-12-31
PH13773A (en) 1980-09-23
FI54606C (en) 1979-01-10
FR2253531B1 (en) 1978-07-21
DE2455859C2 (en) 1983-12-15
DK136780C (en) 1978-05-01
NO744292L (en) 1975-06-30
FR2253531A1 (en) 1975-07-04
CA1030469A (en) 1978-05-02
NZ176117A (en) 1981-05-01
NL179220B (en) 1986-03-03
DE2455859A1 (en) 1975-06-12
NL179220C (en) 1986-08-01
ES432559A1 (en) 1977-03-01
SE423720B (en) 1982-05-24
DD115695A5 (en) 1975-10-12
IE40549B1 (en) 1979-06-20
DK136780B (en) 1977-11-21
NL7415682A (en) 1975-06-10
DK617074A (en) 1975-07-28
FI771201A (en) 1977-04-15
JPS5615235B2 (en) 1981-04-09
IE40549L (en) 1975-06-06
AU7608174A (en) 1976-06-10
FI52851B (en) 1977-08-31
FI343474A (en) 1975-06-07
IL46180A0 (en) 1975-03-13
JPS5089598A (en) 1975-07-18

Similar Documents

Publication Publication Date Title
FI52851C (en) Process for the preparation of the novel therapeutically useful peptide antibiotics S 7481 / F-1 and S 7481 / F-2.
CA981021A (en) Glass ceramic material
CA967368A (en) Glass ceramic material
CA979023A (en) Monolithic refractory materials
CA1011189A (en) Refractory materials
CA1023912A (en) Preparation of fibres from polymeric materials
CA980367A (en) Ceramic material
CA1024130A (en) Ceramic materials
SE424994B (en) PROCEDURE FOR THE PREPARATION OF NEW PSEUDOTRISACCARIDES
SE416731B (en) PROCEDURE FOR THE PREPARATION OF NEW PENICILLINES
ATA392073A (en) Process for the preparation of novel cephalosporin antibiotics
NO139522C (en) PROCEDURE FOR THE PREPARATION OF DEOXYAMINO-GLYCOSIDE ANTIBIOTICS
CA990739A (en) Refractories
AU466331B2 (en) Preparation of n-(1-ethyl-pyrrolidylmethyl)-2-methoxy-5-sulfonamidobenzamide
NO139864C (en) B PROCEDURE FOR THE PREPARATION OF THE ANTIBIOTIC FORTIMICIN
SE7608016L (en) PROCEDURE FOR THE PREPARATION OF NEW ANTIBIOTICS NAMED A 28695 A AND A 28695 B
SE415975B (en) PROCEDURE FOR THE PREPARATION OF NEW BENZYLPYRIMIDINES
AU4671572A (en) Pharmaceutical intermediates
CA1012044A (en) Interferon assay
CA976974A (en) Preparation of n-(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulphonyl-benzamide
AU477307B2 (en) Novel intermediates for preparing semisynthetic penicillins and cephalosporins and processes relating thereto
FI50411C (en) Process for the preparation of arylamino-2-imidazolines
FI47482C (en) Analogous process for the preparation of novel, anti-inflammatory and g estagent active 6-halo-21-fluoro-3,16,17-trihydroxypregna-4,6-die n-20-derivatives.
FI52583C (en) Process for the preparation of novel therapeutically active 4H-s-triazolo- (4,3-a) (1,4) benzodiazepine-1-carboxaldehyde dialkyl acetal.
CA867355A (en) Process for the preparation of biologically active polypeptides